Coherus BioSciences, Inc. (NASDAQ:CHRS) Short Interest Up 9.3% in May

Coherus BioSciences, Inc. (NASDAQ:CHRS – Get Rating) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 13,010,000 shares, an increase of 9.3% from the May 15th total of 11,900,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is […]

Related Keywords

Dennism Lanfear ,Alan Herman ,Steve Glover ,Doug Farrar ,Coherus Biosciences ,Maxim Group ,Coherus Biosciences Inc ,Metlife Investment Management ,Nasdaq ,Coherus Biosciences Company Profile ,Commonwealth Of Pennsylvania Public School Empls Retrmt ,Blackrock Inc ,Get Rating ,Life Investment Management ,Pennsylvania Public School Empls Retrmt ,Redwood City ,Coherus Biosciences Daily ,Nasdaq Chrs ,Chrs ,Medical ,Stocks ,Options ,Put ,Call ,